Botensilimab and Balstilimab for MSS mCRC
Botensilimab ± Balstilimab for Refractory Microsatellite-Stable Metastatic Colorectal Cancer Without Liver Metastases

Released: February 04, 2025

Expiration: August 03, 2025

Activity

Progress
1
Course Completed